Delivery Order SPE2DB20D3103-SPE2DB25FP8C1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,673.51 to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Exforge is a combination antihypertensive medication used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $1,992.17 to AmerisourceBergen Drug Corp for Exforge 10-160 mg tablets (30-count supply) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a $3,788.86 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Exforge 10-160 mg tablets (30-count packaging). This is a firm fixed-price delivery order with a completion date of May 13, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Exforge 5-160 mg tablets (30-count units) with a contract ceiling value of $2,250.48. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a $15,095.94 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Exforge 10-160 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 17, 2025, for Exforge 5-320 mg tablets (30-count units) valued at $2,867.33. This competitive award, issued without set-aside designation, represents a firm fixed-price contract with an ultimate completion date of July 18, 2025. The place of performance is located at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a $6,588.62 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Exforge 10-320 mg tablets (30-count units). This firm fixed price delivery order, with an ultimate completion date of June 3, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count) under a firm fixed-price contract with a ceiling value of $3,399.87. This non-set-aside award, issued on June 25, 2025, with an ultimate completion date of June 26, 2025, represents a single delivery order for this antihypertensive medication to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,600.01 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count packaging) under a firm fixed-price contract. The delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitively awarded, non-set-aside procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,078.23. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. This is a non-set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the same location designated as...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8C1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $40,865.39 to AmerisourceBergen Drug Corp for Exforge 5-160 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 11, 2025. The award was issued on August 8, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Exforge is a combination antihypertensive medication used to treat high blood pressure, representing part of the company's ongoing pharmaceutical supply deliveries to federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026 that supports global pharmaceutical procurement for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant role in supplying medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contract portfolio reflects its status as a critical vendor for military medical supply chains, with deliveries spanning multiple therapeutic domains including chronic disease management, specialty medications, and general healthcare commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.9k | 8/8/25 |